Glenmede Trust’s Cytosorbents Corp CTSO Stock Holding History

Glenmede Trust’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,229	Closed	-$17K	–	1455
2020 Q3	$17K	Buy	2,229 +68	+3%	+$614	﹤0.01%	1671
2020 Q2	$20K	Hold	2,161	–	–	﹤0.01%	1592
2020 Q1	$8K	Hold	2,161	–	–	﹤0.01%	2509
2019 Q4	$8K	Hold	2,161	–	–	﹤0.01%	2509
2019 Q3	$10	Hold	2,161	–	–	﹤0.01%	2340
2019 Q2	$14	Hold	2,161	–	–	﹤0.01%	2218
2019 Q1	$16	Hold	2,161	–	–	﹤0.01%	2171
2018 Q4	$16	Buy	+2,161	New	+$21.5K	﹤0.01%	2082
2018 Q3	–	Sell	-8,662	Closed	-$98K	–	1525
2018 Q2	$98K	Buy	+8,662	New	+$82K	﹤0.01%	1264
2017 Q4	–	Sell	-19,008	Closed	-$117K	–	2690
2017 Q3	$117K	Hold	19,008	–	–	﹤0.01%	1382
2017 Q2	$84K	Hold	19,008	–	–	﹤0.01%	1431
2017 Q1	$84K	Hold	19,008	–	–	﹤0.01%	1431
2016 Q4	$102K	Hold	19,008	–	–	﹤0.01%	1397
2016 Q3	$121K	Hold	19,008	–	–	﹤0.01%	1346
2016 Q2	$85K	Hold	19,008	–	–	﹤0.01%	1395
2016 Q1	$73K	Hold	19,008	–	–	﹤0.01%	1406
2015 Q4	$105K	Sell	19,008 -8,640	-31%	-$58.8K	﹤0.01%	1345
2015 Q3	$173K	Hold	27,648	–	–	﹤0.01%	1213
2015 Q2	$169K	Hold	27,648	–	–	﹤0.01%	1274
2015 Q1	$364K	Hold	27,648	–	–	﹤0.01%	1088
2014 Q4	$274K	Buy	+27,648	New	+$271K	﹤0.01%	1168

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Trust's CTSO Position: Q4 2020 in Review

Glenmede Trust sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 2,229 shares — an estimated $17K sold.

Glenmede Trust first reported a position in CTSO in Q4 2014 and held it in 21 quarters. The position peaked at $364K in Q1 2015. 94 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

Glenmede Trust reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 2,229 Cytosorbents Corp shares in Q4 2020, an estimated $17K.
Glenmede Trust first reported a position in Cytosorbents Corp in Q4 2014 and held it in 21 quarters.
Glenmede Trust's Cytosorbents Corp position peaked at $364K in Q1 2015.
94 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.